Results 91 to 100 of about 1,692 (164)

Case series on the effect of ayurvedic medications in the management of symptoms of vulvovaginal atrophy in postmenopausal women. [PDF]

J Ayurveda Integr Med
Surendran ES, Balakrishnan P, Raj LS.
europepmc   +1 more source

An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy. [PDF]

Med Devices (Auckl), 2021
Jonasson AF, Åstrom M.
europepmc   +1 more source

Value of injection of plasma-rich platelets in the vaginal mucosa in cases with vulvovaginal atrophy: a prospective double-blinded randomized controlled study. [PDF]

BMC Womens Health
Hamid ASA, AbdAllah AM, Fathi HM, Eldin AMB, Abd El Hadi RMM.   +4 more
europepmc   +1 more source

Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up. [PDF]

Breast Cancer Res Treat, 2021
Veron L, Wehrer D, Annerose-Zéphir G, Suciu V, Delaloge S, Pistilli B, Chaltiel D, Pautier P.   +7 more
europepmc   +1 more source

Effectiveness of Erbium: YAG Laser in the Treatment of Vulvovaginal Atrophy in Women Who Survived Breast Cancer. [PDF]

J Cosmet Dermatol
Ferreira KST, Lopes GA, Barbosa LA, do Nascimento IJB, Pedrosa MS, Kroumpouzos G, de Oliveira GV.   +6 more
europepmc   +1 more source

Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study. [PDF]

BMC Womens Health, 2021
Berreni N, Salerno J, Chevalier T, Alonso S, Mares P.   +4 more
europepmc   +1 more source

Understanding the Benefits of CO₂ Laser Treatment for Vulvovaginal Atrophy. [PDF]

Medicina (Kaunas)
Jankovic S, Rovcanin M, Tomic A, Jurisic A, Milovanovic Z, Zamurovic M.   +5 more
europepmc   +1 more source

Assessing the Noninferiority of the Spermidine Hyaluronate Complex Relative to 17β-Estradiol Treatment in the Ovariectomized Murine Model of Vulvovaginal Atrophy. [PDF]

J Menopausal Med
Ghisalberti CA, Tezze C.
europepmc   +1 more source

Prevalence of urinary tract infections in women with vulvovaginal atrophy and the impact of vaginal prasterone on the rate of urinary tract infections. [PDF]

Menopause
Rubin R, Sanaee M, Yee A, Moyneur E, Dea K, Dury AY.   +5 more
europepmc   +1 more source

Multifaceted Impact of CO₂ Laser Therapy on Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy and Sexual Function. [PDF]

Healthcare (Basel)
Jankovic S, Rovcanin M, Zamurovic M, Jovanovic B, Raicevic T, Tomic A.   +5 more
europepmc   +1 more source